Early Respiratory Response to Bovine Lipid Extract Surfactant Can Predict Failure of Minimally Invasive Surfactant Therapy
- 5 August 2026
- journal article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
Abstract
Minimally invasive surfactant therapy (MIST) techniques for instillation of surfactant via a thin intratracheal catheter in a spontaneously breathing neonate with respiratory distress syndrome are being increasingly adopted worldwide. We designed this study to describe the short-term respiratory outcomes in neonates who received high-volume bovine lipid extract surfactant (BLES) at 5 mL/kg via MIST and analyze predictors of MIST failure. This was a retrospective, observational cohort study that included all neonates who received BLES via MIST between January 1, 2018 and December 31, 2023. Baseline demographic characteristics, immediate- and short-term respiratory outcomes were compared between patients with MIST success and MIST failure (defined as the need for mechanical ventilation within 7 days of procedure). Predictors of MIST failure were examined using logistic regression models. Of a total of 213 neonates, 41 (19.2%) were deemed MIST failure. Neonates with MIST failure compared with MIST success had lower mean (standard deviation [SD]) gestational age in weeks (29.0 [2.8] vs. 31.3 [3.4], p < 0.001) and lower mean birthweight (SD) (1247.2 [602] vs. 1654.1 [747] g, p <0.001). Neonates with MIST failure had higher preprocedural positive end expiratory pressures and higher oxygen needs than neonates with MIST success. On regression analysis, fraction of inspired oxygen (FiO2) at 1 hour (p = 0.049) and FiO2 at 6 hours (p = 0.03) post-MIST was identified as independent predictors of MIST failure after accounting for differences in baseline characteristics. Successful administration of high-volume surfactant via MIST, without any need of mechanical ventilation within 7 days of procedure was achieved in 80.8% of the cohort with a low MIST failure rate of 19.2%. Oxygen requirements measured at 1- and 6-hour post-MIST serve as independent predictors of MIST failure.Keywords
This publication has 18 references indexed in Scilit:
- Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants(28 +0 to 34 +6 Week) With Respiratory Distress Syndrome: A Randomized Controlled TrialPediatric Pulmonology, 2025
- Incidence, predictors of success and outcome of LISA in very preterm infantsPediatric Pulmonology, 2022
- Efficacy and safety of surfactant administration via thin catheter in preterm infants with neonatal respiratory distress syndrome: A systematic review and meta‐analysisPediatric Pulmonology, 2021
- Guidelines for surfactant replacement therapy in neonatesPaediatrics & Child Health, 2021
- Less invasive surfactant administration: best practices and unanswered questionsCurrent Opinion in Pediatrics, 2020
- High-volume surfactant administration using a minimally invasive technique: Experience from a Canadian Neonatal Intensive Care UnitPaediatrics & Child Health, 2018
- Rigid catheters reduced duration of less invasive surfactant therapy procedures in manikinsActa Paediatrica, 2017
- Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysisArchives of Disease in Childhood - Fetal and Neonatal Edition, 2016
- Lung Disease in Premature Neonates: Radiologic-Pathologic CorrelationRadioGraphics, 2005
- Lung Development, Surfactant and Respiratory Distress SyndromePediatrics International, 1990